NCT04753970 - Retina is a Marker for Cerebrovascular Heath | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

February 9, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Cerebral Small Vessel DiseasesCerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathyCerebral MicrobleedingSporadic White Matter Disease

Interventions

DRUG

Cilostazol

Cilostazol 100mg BID

Trial Locations (1)

32224

RECRUITING

Mayo Clinic Florida, Jacksonville